Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | May 2014 |
| End Date: | August 2014 |
A Description of Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Including Initiation, Switching, and Discontinuation
This protocol is for a series of descriptive analyses conducted within a cohort of patients
using linagliptin, other dipeptidyl peptidase-4 (DPP-4) inhibitors, and other oral and
non-insulin injected hypoglycemic medications between May 2011 and July 2012.
Understanding 1) the existing utilization patterns for linagliptin, sitagliptin,
saxagliptin, and other oral and non-insulin injected hypoglycemic agents and (2) the
differences in utilization patterns between these agents will help with the design, analysis
and interpretation of comparative effectiveness and safety studies of linagliptin, other
DPP-4 inhibitors, and other agents.
The study will provide an overview of existing utilization patterns for linagliptin, other
dipeptidyl peptidase-4 (DPP-4) inhibitors, other oral and non-insulin injected hypoglycemic
agents, in order to detect potential selective prescribing patterns that might lead to
channeling bias.
using linagliptin, other dipeptidyl peptidase-4 (DPP-4) inhibitors, and other oral and
non-insulin injected hypoglycemic medications between May 2011 and July 2012.
Understanding 1) the existing utilization patterns for linagliptin, sitagliptin,
saxagliptin, and other oral and non-insulin injected hypoglycemic agents and (2) the
differences in utilization patterns between these agents will help with the design, analysis
and interpretation of comparative effectiveness and safety studies of linagliptin, other
DPP-4 inhibitors, and other agents.
The study will provide an overview of existing utilization patterns for linagliptin, other
dipeptidyl peptidase-4 (DPP-4) inhibitors, other oral and non-insulin injected hypoglycemic
agents, in order to detect potential selective prescribing patterns that might lead to
channeling bias.
Inclusion criteria:
- diagnosis of type 2 diabetes mellitus
- a dispensing of an oral or non-insulin injected hypoglycemic medication between May
2011 and June 2012
- at least 6 months enrolment in the database preceding the date of the first
dispensing
Exclusion criteria:
- age < 18
- missing or ambiguous age or sex information
- at least one diagnosis of type 1 diabetes mellitus or secondary diabetes
We found this trial at
1
site
Click here to add this to my saved trials
